IP Library Granted Patent US 9,040,509
Granted Patent B2
US 9,040,509 · App. 13/017,858 · Granted May 26, 2015

Method of treating human skin and a skin care composition for use in such a method

Inventors: Herman Jan Tijmen Coelingh Bennink (Driebergen, NL); Evert Johannes Bunschoten (Heesch, NL); Christian Franz Holinka (New York, NY)
Assignee: Pantarhei Bioscience B.V.
A61Q19/004A61K8/63A61K9/0014A61K31/565A61Q19/00A61Q19/08A61K47/22A61K47/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,040,509
App. No.
13/017,858
Granted
May 26, 2015
Kind
B2
Abstract

One aspect of the invention concerns a cosmetic method of treating human skin by delivering an estrogenic component to said skin. The method comprises applying to the skin a composition containing: (i) at least 5 μg/g of an estrogenic component selected from the group consisting of substances represented by the following formula (I) in which formula R 1 , R 2 , R 3 , R 4 independently are a hydrogen atom, a hydroxyl group or an alkoxy group with 1-5 carbon atoms; each of R 5 , R 6 , R 7 is a hydroxyl group; no more than 3 of R 1 , R 2 , R 3 , R 4 are hydrogen atoms; precursors capable of liberating a substance according to the aforementioned formula when used in the present method; and mixtures of one or more of the aforementioned substances and/or precursors; and (ii) a cosmetically acceptable vehicle. Other aspects of the invention relate to therapeutic methods of treating or preventing vaginal dryness or acne and a therapeutic method of promoting wound healing. Yet another aspect of the invention relates to a skin care composition comprising the aforementioned estrogenic component and a cosmetically acceptable vehicle.

Claims (19)

1. A cosmetic method of improving wrinkled, lined, dry, flaky, aged, or photodamaged skin comprising applying to the skin a composition comprising:

(i) at least 5 μg of estetrol per g of composition; and

(ii) a cosmetically acceptable vehicle.

2. The cosmetic method according to claim 1 , wherein the composition enhances proliferation of fibroblasts and/or epidermal skin cells.

3. The cosmetic method according to claim 1 , wherein the composition improves skin thickness and/or skin elasticity.

4. The method according to claim 1 , wherein the composition contains at least 10 μg/g of estetrol.

5. The cosmetic method according to claim 1 , wherein the composition is applied to facial skin or neck skin.

6. The cosmetic method according to claim 1 , wherein the composition is applied at least once a day during a period of at least 3 days.

7. The cosmetic method according to claim 1 , wherein virtually all of the composition that has been applied to the skin penetrates the skin.

8. A method of promoting wound healing comprising applying to a wounded tissue or to tissue in a vicinity of a wound a composition comprising:

(i) at least 5 μg of estetrol per g of composition; and

(ii) a cosmetically acceptable vehicle.

9. A method of treating or preventing acne comprising applying to skin that is affected by acne or that is at risk of being affected by acne a composition comprising:

at least 5 μg of estetrol per g of composition; and

(ii) a cosmetically acceptable vehicle.

10. A pharmaceutical or cosmetic composition for topical administration comprising:

at least 5 μg of estetrol per g of composition; and

(ii) a cosmetically acceptable vehicle.

11. The cosmetic method according to claim 1 , wherein the composition is a lotion, salve or a cream.

Assignments (3)
CHANGE OF NAME Recorded Nov 16, 2021
From: ESTETRA SPRL
To: ESTETRA SRL
Reel/Frame 058158/0948 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2020
From: DONESTA BIOSCIENCE B.V.
To: ESTETRA SPRL
Reel/Frame 051777/0010 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2015
From: PANTARHEI BIOSCIENCE B.V.
To: DONESTA BIOSCIENCE B.V.
Reel/Frame 035632/0119 →
Priority Claims (1)
EP 02077273 · Jun 11, 2002 · regional
Continuity (2)
Division 10517509
Related Publication 20110160173A1 · Jun 30, 2011